FDA Drug · D-0008-2026

Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25

Class II · Ongoing

Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.

Affected lots / codes — check yours against thisLot # K250048

Recalling firm: Dr. Reddy's Laboratories, Inc., Princeton, NJ
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 571 vials
Distribution: Nationwide within the USA.
Recall initiated: September 26, 2025
Classified: October 7, 2025
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0008-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →